Finance

Lists
Why is COYA up 3.69%?
Dive Deeper
COYA:NASDAQ
Coya Therapeutics Inc
$4.36
+3.69%
(+0.16) 1D
Oct 20, 10:49:15 AM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for COYA...
Open
$4.22
High
$4.36
Low
$4.22
Mkt. cap
102.16M
Avg. vol.
151.90K
Volume
14.70K
52-wk high
$7.55
52-wk low
$3.71
EPS
-$1.07
Beta
0.58
Shares outstanding
23.46M
No. of employees
8
Open
$4.22
High
$4.36
Low
$4.22
Mkt. cap
102.16M
Avg. vol.
151.90K
Volume
14.70K
52-wk high
$7.55
52-wk low
$3.71
EPS
-$1.07
Beta
0.58
Shares outstanding
23.46M
No. of employees
8
News stories
From web sources and news partners
About Coya Therapeutics Inc
CEO-
Employees8
Founded2020
HeadquartersHouston, Texas, United States
SectorBiotechnology
Websitecoyatherapeutics.com
Analyst ratings
Based on 4 analysts giving stock ratings to COYA in the past 3 months
Strong buy
Buy
4
Hold
0
Sell
0
12-month forecast
Based on 4 Wall Street analysts offering 12 month price targets for COYA in the last 3 months.
Highest
Current $4.36
$18.00 (+313.32%)
Average
$15.75 (+261.65%)
Lowest
$12.00 (+175.55%)
Analyst
Recommendation
Action
Price target
Projected
Date
Boobalan Pachaiyappan
Roth MKM
Buy
Reiterated
$12.00
+175.5%
10/15/2026
Ram Selvaraju
H.C. Wainwright
Buy
Reiterated
$18.00
+313.3%
10/15/2026
Chad Messer
Lake Street
Buy
Reiterated
$17.00
+290.4%
10/06/2026
Thomas Shrader
BTIG
Buy
Maintained
$16.00
+267.4%
08/11/2026
Keay Nakae
Chardan Capital
Buy
Maintained
$14.00
+221.5%
05/12/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
3.56M
3.96M
251.15K
243.74K
Cost of goods sold
2.92M
4.94M
4.10M
5.03M
Cost of revenue
2.92M
4.94M
4.10M
5.03M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2.56M
3.27M
3.78M
2.26M
Operating expense
2.56M
3.28M
3.78M
2.26M
Total operating expenses
5.48M
8.22M
7.88M
7.29M
Operating income
-1.92M
-4.26M
-7.63M
-7.05M
Other non operating income
-
-
-
-
EBT including unusual items
-2.12M
-5.71M
-7.21M
-6.64M
EBT excluding unusual items
-1.60M
-3.93M
-7.20M
-6.64M
Income tax expense
-
3.09K
-
-
Effective tax rate
-
-0.05%
-
-
Other operating expenses
-
-
-
-
Net income
-2.12M
-5.71M
-7.21M
-6.64M
Net profit margin
-59.36%
-144.16%
-2,869.63%
-2,723.44%
Earnings per share
-0.13
-0.34
-0.32
-0.28
Interest and investment income
317.07K
325.44K
433.23K
408.73K
Interest expense
-
-
-
-
Net interest expenses
317.07K
325.44K
433.23K
408.73K
Depreciation and amortization charges
6.84K
6.84K
2.81K
2.81K
EBITDA
-1.91M
-4.25M
-7.63M
-7.04M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps